Bariatric endoscopy opens ‘leadership role’ to GIs for obesity management

Endoluminal therapy for weight loss delivered by flexible endoscopy has had appeal for nearly 20 years. The continued growth in the global prevalence of obesity makes the need for new and better treatment options more critical than ever.Results from the landmark Multicenter ESG Randomized Interventional Trial (MERIT), recently presented at Digestive Disease Week 2022, suggest endoscopic sleeve gastroplasty (ESG) is one such treatment option. But how did we arrive at this place where endoscopic bariatric therapy is positioned to play a leading role in the treatment of obesity?In 2002, theRead More

Related Articles